Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019
OPERATING ACTIVITIES:
Net loss	$ (10,522)	$ (37,908)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
Depreciation and amortization	19,697	9,192
Share-based payment compensation	1,227	1,683
Amortization of deferred financing costs	148	152
Payments for television distribution rights	(5,292)	0
Inventory impairment write-down	0	6,050
Changes in operating assets and liabilities:
Accounts receivable, net	10,055	18,034
Inventories	7,197	(23,577)
Deferred revenue	90	(27)
Prepaid expenses and other	1,472	640
Accounts payable and accrued liabilities	(14,964)	23,006
Net cash provided by (used for) operating activities	9,108	(2,755)
INVESTING ACTIVITIES:
Property and equipment additions	(3,680)	(5,367)
Net cash used for investing activities	(3,680)	(5,367)
FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants	20,043	6,000
Proceeds from issuance of revolving loan	14,400	160,400
Payments on revolving loan	(28,800)	(160,400)
Payments on term loan	(2,036)	(2,035)
Payments for business acquisition	(238)	0
Payments on finance leases	(75)	(46)
Payments for common stock issuance costs	(39)	(109)
Payments for restricted stock issuance	(8)	(21)
Net cash provided by financing activities	3,247	3,789
Net increase (decrease) in cash and restricted cash equivalents	8,675	(4,333)
BEGINNING CASH AND RESTRICTED CASH EQUIVALENTS	10,287	20,935
ENDING CASH AND RESTRICTED CASH EQUIVALENTS	18,962	16,602
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	3,307	2,288
Income taxes paid	80	31
Television distribution rights obtained in exchange for liabilities	30,633	0
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES:
Property and equipment purchases included in accounts payable	459	387
Common stock issuance costs included in accrued liabilities	361	0
Equipment acquired through finance lease obligations	62	188
Issuance of warrants	$ 0	$ 193